FDA orphan drug designation: treatment of myelodysplastic syndrome
All entries for: Minovia Therapeutics Ltd.
October 3, 2025
Minovia Therapeutics Ltd.
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of myelodysplastic syndrome